MedDataX Logo

InnovationForParticipation

NCT05103930 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1055

Last updated 2022-04-04

No results posted yet for this study

Summary

Children with disabilities experience activities limitations and participation restrictions. Facilitating the children with disabilities' independence while performing tasks is a key stake to improve their successful participation and their development.

Products and technology can prevent, compensate, relieve or neutralize disability or handicap and help children and youth with disabilities to perform tasks that might otherwise be difficult or impossible.

The aim of this study was i) to identify the most frequent activity limitations and participation restrictions for which assistive products and technology may be useful for children and youth with disabilities, and ii) to highlight macroscopic trends related to encountered difficulties and wished products and technology.

The hypotheses were i/ that difficulties would be particularly expected for certain life situations, especially outside the home in an unfamiliar environment ii/ that products and technology would be wished for those situations which should be defined as priority subjects and iii/ that thanks to those results it could be possible to highlight new processes to develop innovative solutions.

Conditions

  • Children
  • Disabilities

Sponsors & Collaborators

  • University Hospital, Brest

    lead OTHER

Principal Investigators

  • Sylvain Brochard · CHRU de Brest, Brest, France

  • Christelle Pons · Fondation Ildys

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-11
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • France

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05103930 on ClinicalTrials.gov